XW13325 |
Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5 |
XW1337A |
Transfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10 |
XW133B8 |
Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
XW133C8 |
Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
XW133D7 |
Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
XW133E7 |
Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 |
XW133F8 |
Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
XW133G8 |
Transfusion of OTL-200 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
XW133H9 |
Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9 |
XW133J8 |
Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8 |
XW14325 |
Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5 |
XW1437A |
Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10 |
XW143B8 |
Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8 |
XW143C8 |
Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8 |
XW143D7 |
Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7 |
XW143E7 |
Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7 |
XW143F8 |
Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8 |
XW143G8 |
Transfusion of OTL-200 into Central Vein, Percutaneous Approach, New Technology Group 8 |
XW143H9 |
Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9 |
XW143J8 |
Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8 |